A novel immunotherapy for advanced melanoma.

被引：0
|
作者：
Wang, X
Chen, HY
Lin, JR
Xie, B
Wu, L
Yang, DM
机构：
[1] Liu Hua Qiao Hosp, Guangzhou 510010, Peoples R China
[2] Yangfan Biotech Corp, Mt View, CA 94043 USA
来源：
CLINICAL IMMUNOLOGY | 2002年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
220
引用
收藏
页码：S72 / S73
页数：2
相关论文
共 50 条
  • [31] Multiple primary malignancies among patients with advanced melanoma.
    Ebia, Matthew Isaiah
    In, Gino Kim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [32] Current treatment of advanced melanoma. Dermatooncology update 2022
    Gutzmer, Ralf
    Angela, Yenny
    Alter, Mareike
    [J]. ONKOLOGIE, 2022, 28 (04): : 334 - 339
  • [33] A phase I trial of panobinostat with ipilimumab in advanced melanoma.
    Khushalani, Nikhil I.
    Markowitz, Joseph
    Eroglu, Zeynep
    Giuroiu, Iulia
    Ladanova, Viktoriya
    Reiersen, Pamela
    Rich, Jeani
    Thapa, Ram
    Schell, Michael J.
    Sotomayor, Eduardo M.
    Weber, Jeffrey S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Clinical characteristics predictive of response to pembrolizumab in advanced melanoma.
    Tsai, Katy K.
    Loo, Kimberly
    Khurana, Neharika
    Algazi, Alain Patrick
    Hwang, Jimmy
    Sanchez, Roberto
    Krummel, Matthew
    Rosenblum, Michael
    Tumeh, Paul
    Daud, Adil
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [35] NIVOLUMAB CLEARANCE IS TIME-VARYING IN ADVANCED MELANOMA AND STATIONARY IN ADJUVANT MELANOMA.
    Hamuro, L. L.
    Statkevich, P.
    Bello, A.
    Roy, A.
    Bajaj, G.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S68 - S68
  • [36] Neoadjuvant combination immunotherapy with pembrolizumab and high dose IFN-α2b in locally/regionally advanced melanoma.
    Tarhini, Ahmad A.
    Lin, Yan
    Drabick, Joseph J.
    Neves, Rogerio Izar
    Ernstoff, Marc S.
    Puzanov, Igor
    Vallabhaneni, Priyanka
    Pingpank, James F.
    Holtzman, Matthew Peter
    Sander, Cindy
    Kirkwood, John M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [37] Combined chemo-immunotherapy for metastatic melanoma. A monoinstitutional experience.
    Di Lauro, V
    La Mura, N
    Zanetti, M
    Scalone, S
    Lombardi, D
    Freschi, A
    Veronesi, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 727S - 727S
  • [38] A New Combination Immunotherapy in Advanced Melanoma
    Frampton, Adam E.
    Sivakumar, Shivan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (01): : 91 - 92
  • [39] Immunotherapy for advanced melanoma: future directions
    Valpione, Sara
    Campana, Luca G.
    [J]. IMMUNOTHERAPY, 2016, 8 (02) : 199 - 209
  • [40] Neoadjuvant Immunotherapy for Locally Advanced Melanoma
    Pelster, Meredith S.
    Amaria, Rodabe N.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (02)
12345